chrisvoncsefalvay/vaers-outcomes huggingface dataset:
she had a problem breathing/out of breath; asthma; This is a spontaneous report from a contactable consumer (patient's mother). A 42-year-old female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE), dose 2 via an unspecified route of administration on an unspecified date (Batch/Lot number was not reported) at single dose for covid-19 immunisation. The patient's medical history and concomitant medications were not reported. The patient previously received the first dose of bnt162b2 on an unspecified date for covid-19 immunisation. Reporter was calling on behalf of her daughter, she had both doses of Pfizer vaccine. She was in a clinical trial at (withheld), 6 hours after the second dose she had a problem breathing. She had been in and out of ICU ever since then. She had been going to Emergency Room, they were saying it was asthma, they didn't know how to treat it. She was scheduled to go to (withheld) clinic tomorrow. The insurance contacted her and said she can't go there, here Insurance won't cover it. She had been to several doctors in and around Toledo, doctors just didn't know what's wrong, she can't breath, she was on 4 different inhalers. She started CPAP machine, She had 2 sleep studies, got a CPAP, she was nurse with no breathing problems before this. She was on 10 different medications in the morning and not sure how many at night. She went to her family doctor, when she got out of ICU, they didn't know how to treat her. She did not respond, it felt like they didn't know what to do. Her primary care physician wanted her to go to (withheld) Clinic. She can't walk but a few steps, she was out of breath. Reporter just wondered if there was any place she could go and get help or see someone who might have experience in dealing with this. Reporter was going to reach out to the personal care physician. She just can't breathe. The final outcome of the events was unknown.  No follow-up attempts are possible; information about lot/batch number cannot be obtained.
This spontaneous report was received from a registered pharmacist refers to a female patient who is a staff member, of unknown age. On an unknown date many years ago the patient was vaccinated with dose 1 M-M-R II (lot#, expiration date and route not reported). Patient did not have documentation of receiving first dose of M-M-R II. Approximately on an unknown date in 2013 (reported as couple weeks ago) the staff members titer levels were measured and she was found to have a negative mumps titer. Pharmacist reported that dose 2 of M-M-R II (lot#, expiration date 12-AUG-2012 and route not reported) was administered to her because of the negative mumps titer but the dose of M-M-R II was expired. No symptoms reported. No other details. Outcome of the reported event was unknown. No treatment was given for the event. Patient sought an unspecified medical attention. Causality was not reported. Additional information has been requested.
Parents returned to health department to report right arm swelling, redness, (2cm) Pain, No fever reported. Onset 03/29/2005-child reported after returning from school. Received Td (3) in right arm 9:00 AM 03/28/2005. Cold compress applied to site in clinic. Advised Tylenol and  continue with compress. 03/30/2005- Child's arm improved no need for f/u visit. Redness none.
Approximate 6 inch band around childs upper arm between shoulder and elbow, warm, itchy, painful. No weeping. No fever.
Swelling right arm pit, very large size of a lemon, severe pain, resolving with warm compresses after 4 days.As of 4/15/2021 slight persistent swelling. Severe chills, no fever 4/8/2021 thru 4/9/2021, diminishing over time. Severe headaches, starting 4/9/2021, lasting for 6-8 hours, refractive to acetomenaphin, ibuprophen. Continuing through 4/14/2021.  Suspected gallbladder involvement.
Feels like a train hit her and she can pass out; Fever of 102; Chills; Body aches; Nausea; This spontaneous case was reported by a consumer and describes the occurrence of FATIGUE (Feels like a train hit her and she can pass out), PYREXIA (Fever of 102), CHILLS (Chills), MYALGIA (Body aches) and NAUSEA (Nausea) in a 59-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 026B21A and 036A21A) for COVID-19 vaccination.     No Medical History information was reported.   On 06-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 04-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 04-Apr-2021, the patient experienced FATIGUE (Feels like a train hit her and she can pass out), PYREXIA (Fever of 102), CHILLS (Chills), MYALGIA (Body aches) and NAUSEA (Nausea). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency. At the time of the report, FATIGUE (Feels like a train hit her and she can pass out), PYREXIA (Fever of 102), CHILLS (Chills), MYALGIA (Body aches) and NAUSEA (Nausea) outcome was unknown.            No concomitant medications reported by patient.  Action taken with mRNA-1273 in response to the events was not applicable.
Sore arm, swollen arm, fatigue, nausea, dizziness, body ache, joint pain
hair loss; Vertigo; immune defenses on overdrive; This spontaneous case was reported by a consumer and describes the occurrence of ALOPECIA (hair loss), VERTIGO (Vertigo) and IMMUNE SYSTEM DISORDER (immune defenses on overdrive) in a 66-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 015M20A) for COVID-19 vaccination.     The patient's past medical history included COVID-19. Concomitant products included ESTROGEN NOS, COLECALCIFEROL (VITAMIN D [COLECALCIFEROL]) and FISH OIL for an unknown indication.    On 03-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 13-Mar-2021, the patient experienced ALOPECIA (hair loss), VERTIGO (Vertigo) and IMMUNE SYSTEM DISORDER (immune defenses on overdrive). At the time of the report, ALOPECIA (hair loss), VERTIGO (Vertigo) and IMMUNE SYSTEM DISORDER (immune defenses on overdrive) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Other Concomitant Medications included multivitamin.   No Treatment History was provided.
Pregnant patient reported on 312MAR2021 that she received the Covid vaccine on 26MAR2021; This spontaneous prospective pregnancy case was reported by a consumer and describes the occurrence of MATERNAL EXPOSURE DURING PREGNANCY (Pregnant patient reported on 312MAR2021 that she received the Covid vaccine on 26MAR2021) in a 36-year-old female patient (gravida 5, para 1) who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 37a2113) for COVID-19 vaccination.     The patient's past medical history included No adverse event. Concomitant products included MAGNESIUM, VITAMIN D3 and PRENATAL + DHA for an unknown indication.    On 26-Mar-2021 at 3:00 AM, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. The patient's last menstrual period was on 20-Aug-2020 and the estimated date of delivery was 27-May-2021. On 26-Mar-2021, the patient experienced MATERNAL EXPOSURE DURING PREGNANCY (Pregnant patient reported on 312MAR2021 that she received the Covid vaccine on 26MAR2021). The patient received mRNA-1273 (Moderna COVID-19 Vaccine) beginning around the  thirty-first week of the pregnancy.  On 26-Mar-2021, MATERNAL EXPOSURE DURING PREGNANCY (Pregnant patient reported on 312MAR2021 that she received the Covid vaccine on 26MAR2021) had resolved. Not Provided    DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 11-Sep-2020, Pregnancy test: positive (Positive) positive. On an unknown date, Glucose tolerance test: normal (normal) normal. On an unknown date, Ultrasound antenatal screen: normal (normal) normal.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Treatment information was not provided. 22-May-2016, patient had live full term birth
Flu like symptoms with aches, fever, stomach ache, fatigue, congestion, cough.
NO symptoms for 2 days after 2nd dose, but 58 hours later I woke up at 1am and couldn't walk. I could not lift my left leg off the floor to put weight on right leg. Didn'  t want to take Tylenol/ibuprofen so took a Xanax (low dose) to help sleep. Had a chiropractic adjustment the next day; needed cane & wheelchair for access (extremely painful & slow walking.) Took a 4 hour flight 2 days later. Was semi mobile, but knee stiff & needed a walker. Throbbing behind right knee & in groin; went to the ER for a dopplar ultrasound to rule out blood clots. It was osteoarthritis with no evidence of blood clots. Came home on 4/7. had several chiropractic adjustments. Now more mobile, still need cane/walker for stability.
0.3 ml dose was drawn up from Pediatric Pfizer vial and administered to patient. Patient received 0.3 ml of the Pediatric Pfizer vaccine instead of 0.3 ml of the adult Pfizer. The patient was notified as soon as it was discovered and advised to return to get 0.3ml of the 12+ adult pfizer vaccine. Patient will comeback in on Monday. Patient returned on 12/06/2021 and was given the replacement dose of 0.3ml of the adult pfizer vaccine.on  No adverse events were reported.
burning; tingling; This spontaneous case was reported by a pharmacist and describes the occurrence of BURNING SENSATION (burning) and PARAESTHESIA (tingling) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No patients medical history was provided.     On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced BURNING SENSATION (burning) and PARAESTHESIA (tingling). At the time of the report, BURNING SENSATION (burning) and PARAESTHESIA (tingling) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant medications reported. No treatment medications provided by the reporter.   This case was linked to MOD21-081833, US-MODERNATX, INC.-MOD-2021-090391, US-MODERNATX, INC.-MOD-2021-090401 (E2B Linked Report).; Sender's Comments:  MOD21-081833:crosslinked US-MODERNATX, INC.-MOD-2021-090401:Same reporter US-MODERNATX, INC.-MOD-2021-090391:Same reporter
Donor appeared with a rash with raised bumps on his right upper arm, a few on his right antecubital fossa area and a small patch on his right inner forearm. Donor states that he has the rash for about a week now. After speaking with donor on 12/11/2018, donor states that the areas have cleared up on 12/09/2018.
3 days after vaccine, developed swelling and urticaria around injection site (L) arm; still persistent 6 days later.
Information has been received from a physician concerning a 14 year old female who was IM vaccinated with her first dose of GARDASIL (lot number unspecified).  Concomitant therapy included MENACTRA in a different arm.  On 26-FEB-2008 the patient experienced hives in the area below the injection site.  The patient sought medical attention by contacting the physician.  Subsequently, the patient recovered from hives at an unknown date.  Additional information has been requested.
migraine including eye pain, headache, neck pain, light sensitivity leading to ER visit, dismissed with minimal improvement, second ER visit two days later following neurology recommending urgent admission, admitted at hospital to treat migraine, discharged w/ minimal improvement to neurology follow up: chronic daily headaches persisting since second vaccine dose
I experienced facial numbness, headache, chills, confusion, and aphasia for approximately 30 minutes.  Symptoms slowly resolved (gone 90 minutes from onset).
Cellulitis: red, warm to the touch, hard, right leg 9.5x7.5. Benadryl monitor.
VAERS completed because of being Tested positive for COVID-19 infection 14 or more days after being fully vaccinated. 1st dose01/06/21 2nd dose01/27/21 Diagnosed covid positive:08/23/21 Symptom onset:08/15/21 Exposure:Home Symptoms:fever,muscle aches, abd pain, loss of smell/taste, sore throat,diarrhea, runny nose chills.
chills; fever; This is a spontaneous report from a contactable consumer reporting on behalf of the patient. A 78-year-old male patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration on 23Feb2021 at 11:30 am (Lot Number: EN6198; Expiration Date: 30Jun2021; at the age of 78 years old) as dose 1, single for COVID-19 immunisation. The patient's medical history and concomitant medications were not reported. The patient received the 1st dose of the COVID vaccine on 23Feb2021 at around 11:30 am. An hour after he got home from getting the vaccine on 23Feb2021, the patient experienced chills and fever. Symptoms were treated with Tylenol. The reporter would like to know how fast the side effects from the COVID vaccine can appear and would like to know how long the side effects could last. The patient has not yet recovered from the events. The events were assessed as non-serious.   No follow-up attempts are possible; information about batch number was already obtained.
Approx 5 minutes after receiving vaccine, patient complained of 'feeling dizzy', diaphoresis.  This lasted approx 5- 10 minutes, then patient states arms and legs were 'itchy'.  Redness noted on forearms where patient had been scratching. No swelling, SOB, cough noted.  At this time, patient was assessed by doctor and requested diphenhydramine for symptoms.  Patient was given diphenhydramine 50mg PO and monitored for 30 minutes.  Per patient, all symptoms resolved.  Patient was advised to go directly to ED for return of symptoms or any other side effects.
Patient reported experiencing nausea/vomiting and hoarseness approximately 4 hours after receiving two immunizations. Hoarseness continued into following day.
This case was reported by a consumer via call center representative and described the occurrence of fever in a 70-year-old female patient who received SHINGRIX for prophylaxis. On 14th February 2019, the patient received the 1st dose of SHINGRIX (intramuscular). On 14th February 2019, less than a day after receiving SHINGRIX, the patient experienced pain in arm. On 15th February 2019, the patient experienced fever, feeling bad and headache. On an unknown date, the outcome of the fever, feeling bad and headache were not recovered/not resolved and the outcome of the pain in arm was recovered/resolved. It was unknown if the reporter considered the fever, pain in arm, feeling bad and headache to be related to SHINGRIX. dditional details were provided as follows: 1 day after receiving SHINGRIX, the patient experienced fever, headache and has felt lousy. The patient's arm was also sore for a long timeafter receiving SHINGRIX. The patient went to urgent care and it was found that she does not have any sinus infection or congestion to explain the headache or fever. The reporter consented to follow up.
pt recv vax 29AUG97 pt devel a sterile abscess @ inj site;the abscess was surgically removed on an outpatient basis on 22SEP97;
115PM pt recv vax & 1min p/vax pt collapsed onto the table w/sz-like activity of inc extremities w/apnea & cyanosis of hands x 1min;911 was called & 02 was ready to be given when episode ended;pt frightened & whined;dx syncope episode;
pt recvd vax & approx 3 months p/vax dx w/GBS (JAN94);
Fever 101 degrees for 2 days, then diarrhea, lost appetite, drowsy, fussy and whole body rash that looked like measles on 09/10/2016 and 09/11/2016.
Janssen COVID-19 Vaccine Body Chills and teeth chattering 3/23/2021 @ 6pm  Body Hot/overheated 3/23/2021 @ 11pm Sweating and felt overheated Fainted 3/24/2021 @ 5:36am
24 hours after the vaccination I had a loud ringing in my right ear and I still have it. Its not every day, 5 out of 7 days I will have ringing in my right ear.  Some days louder than other days. And I never had ringing in my ears before. I did not experience any ringing with my 1st dose. It was 24 hours right after the 2nd dose when I started to experience ringing in my right ear. I went to my primary he said there was no pressure on my eardrums. He referred my to an ENT. In July, I saw an ENT, he had my hearing tested with an otologist . my hearing is diminished  in my  right ear. I can't hear tones  well because of the ringing . The ENT wants to do an MRI with contrast. I have claustrophobia and I have been putting it off.  I am not experiencing any other symptoms like headache. I just have severe tinnitus in my right ear now .  I was hoping the ringing would subside but it is now August, and I feel that I will have to now live with this ringing in my ear.
Fever up to 102 accompanied by headache, fatigue and significant body aches. Onset of severe symptoms about 12.5 hours after administration, treated with Tylenol (1gm q6H) and ibuprofen 600mg q6H alternating. Fever initially unresponsive to antipyretic. 24 hours post-administration has decreased to 99.4.
Information has been received from a pharmacist concerning a 21 year old female with migraines and an allergy to VICODIN who on 11-FEB-2008 was vaccinated with her second dose of Gardasil (lot # 654702/0011U). Concomitant therapy included birth control (unspecified). On 11-FEB-2008 the patient was seen in the office and developed nausea, blurred vision, dizziness, tinnitus, lightheadedness and felt like she was going to faint after her second vaccination with Gardasil. Her blood pressure was 84/58 and her pulse was 81. She was slightly hypoxic with an oxygen level of 84. On 11-FEB-2008, she was treated with oxygen and recovered. Additional information has been requested.
Fainted after last of the three vaccines was given. Pt immediately reported she felt faint, I immediately laid her back on the table. There was a slight LOC, but upon MD coming in the room seconds later the patient had eyes open and confused as to what had happened. I had her on the table laying down until she was able to tolerate sitting up. Once able to do this the pt tolerated water and pretzels and was feeling better but still slightly nauseous. Ambulated to the car with mother and sister.
reaction to a Moderna vaccine/unknown reaction; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION COMPLICATION (reaction to a Moderna vaccine/unknown reaction) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. #029L24A) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 28-Jun-2021, the patient experienced VACCINATION COMPLICATION (reaction to a Moderna vaccine/unknown reaction). At the time of the report, VACCINATION COMPLICATION (reaction to a Moderna vaccine/unknown reaction) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were reported. No treatment medications were reported.
administered adjuvant suspension only; administered adjuvant suspension only; This case was reported by a other health professional via sales rep and described the occurrence of inappropriate preparation of medication in a 60-year-old male patient who received Herpes zoster (Shingrix) (batch number FZ7Z4, expiry date 27th January 2023) for prophylaxis.   On 22nd September 2021, the patient received Shingrix. On 22nd September 2021, unknown after receiving Shingrix, the patient experienced inappropriate preparation of medication and inappropriate dose of vaccine administered. On an unknown date, the outcome of the inappropriate preparation of medication and inappropriate dose of vaccine administered were unknown.  Additional details provided were as follows: The case was reported by sales representative. The office manager was called and said that they have given 2 appropriate doses of Shingrix to 2 patient out of the box of 10 and the 8 remaining doses they gave just the adjuvant solution which led to  inappropriate preparation of medication and inappropriate dose of vaccine administered. They do not remember which of the 10 patient got the full dose. The reporter did not consented to follow-up. Sales representative stated that the health care professional declined to follow up the case. This case is 1 of 9 case linked, reported by same reporter.; Sender's Comments:  US-GLAXOSMITHKLINE-US2021209458:same reporter US-GLAXOSMITHKLINE-US2021209462:Same reporter. US-GLAXOSMITHKLINE-US2021209467:Same reporter. US-GLAXOSMITHKLINE-US2021209470:Same reporter. US-GLAXOSMITHKLINE-US2021209463:Same reporter. US-GLAXOSMITHKLINE-US2021209483:Same reporter US-GLAXOSMITHKLINE-US2021209468:Same reporter. US-GLAXOSMITHKLINE-US2021209478:Sam reporter
Initially I had a more severe pain than i had with the first dose.  Swelling and Soreness at the injection site was worse than the first dose.  Later at night when trying to go to sleep I felt a SUDDEN Onset of CHILLS.  I then had Muscular Pain thruout various parts of my body.  I had Headache.  I felt cold thruout the first night after I got the vaccine.  I felt tired and unable to do day to day tasks the following day.
Headache in forehead area, by 10:00 PM chills, shaking, lightheaded; alternating with low-grade fever 99.7 symptoms subsided after 4 hours; October 23, 2013 7:00 AM tired, muscle and joint aches with no chills or body shakes; slept 4 hours awoke about 3:00 PM slightly tired no headache.
Within 15min of vaccine, pt reports feeling dizzy, nauseous, tingling of mouth/arm and flushing of face as well as "not feeling right". Left for urgent care at 12:15 PM.
lymphadema; This spontaneous case was reported by a consumer and describes the occurrence of LYMPHEDEMA (lymphedema) in a 76-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 040A21A) for COVID-19 vaccination.     The patient's past medical history included No adverse event. Concomitant products included COLECALCIFEROL (VIT D [COLECALCIFEROL]), ACETYLSALICYLIC ACID (ASPIRIN (E.C.)), VITAMIN B COMPLEX and MULTIVITAMINS [VITAMINS NOS] for an unknown indication.    On 09-Mar-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 10-Feb-2021, the patient experienced LYMPHEDEMA (lymphedema). The patient was treated with IBUPROFEN (oral) at an unspecified dose and frequency. At the time of the report, LYMPHEDEMA (lymphedema) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Concomitant medications included Multivitamins, Treatment details included Ibuprofen and compression bag physical therapy.  Action taken with response to the events are not applicable   This case was linked to US-MODERNATX, INC.-MOD-2021-074688 (E2B Linked Report). This case was linked to MOD-2021-074688 (Patient Link).; Sender's Comments:  US-MODERNATX, INC.-MOD-2021-074688:1st dose
Ongoing Pericarditis (chest tightness during exercise, fatigue, muscle soreness)